The story of Pauline Williams, a 63-year-old woman who suffers from blepharospasm—a neurological problem that causes the muscles in her eyes to forcibly contract, leaving her unable to open her eyes ...
RALEIGH, N.C.--(BUSINESS WIRE)--Merz Americas announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for XEOMIN ® ...
Thirty years ago, blepharospasm -- a condition in which involuntary muscle contractions can cause the eyelid to close -- was misdiagnosed as dry eye, an allergy problem or nervous habit. There was no ...
When a medicine's side effects turn out to be more marketable than its intended purpose, people tend to forget what the intended purposes were. The "little blue pill" never quite became synonymous ...
PHILADELPHIA — IncobotulinumtoxinA (Xeomin, Merz Pharmaceuticals) conveys long-term safety and efficacy in patients with benign essential blepharospasm (BEB) who are botulinum toxin-naïve, new ...
Dear Dr. Roach: I have been contending with blepharospasm for years. I got some relief from Botox for around four years, but then it stopped working and my doctor moved me to Dysport, which was ...
NORTH CHICAGO, Ill., Feb. 10, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) has approved BOTOX® for the treatment of ...
Philip Crilly does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback